Michael J. Fox Foundation for Parkinson's Research Announces Promising Results, Next Steps for "Ken Griffin Alpha-synuclein Imaging Competition"

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Author(s): PR Newswire
  • Source:
    PR Newswire US. 03/28/2023.
  • Additional Information
    • Alternate Title:
      MJFF-competition
    • Subject Terms:
      New York
    • Abstract:
      NEW YORK, March 28, 2023 /PRNewswire/ -- Today, The Michael J. Fox Foundation for Parkinson's Research (MJFF) announced the culmination of the "Ken Griffin Alpha-synuclein Imaging Competition," a $10-million program launched in 2019 in pursuit of an imaging tracer to visualize the key protein alpha-synuclein in the living brains of people with Parkinson's disease (PD). Funded by a leadership gift from Citadel founder and CEO Ken Griffin, the competition has been a critical step in MJFF's relentless pursuit of better treatments, cures and disease prevention. [ABSTRACT FROM PUBLISHER]